Hussman Strategic Advisors, Inc. Acadia Pharmaceuticals Inc Transaction History

Hussman Strategic Advisors, Inc.

  • $386 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$20.84 - $33.47 $416,800 - $669,400
-20,000 Reduced 32.26%
42,000 $875,000
Q2 2023

Aug 03, 2023
SELL
$17.8 - $25.65 $551,800 - $795,150
-31,000 Reduced 33.33%
62,000 $1.48 Million
Q1 2023

May 04, 2023
BUY
$16.32 - $20.92 $1.52 Million - $1.95 Million
93,000 New
93,000 $1.75 Million

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email